Genelabs, GlaxoSmithKline deal

GlaxoSmithKline extended to Jan. 6 from Dec. 29, 2008, its $1.30 per share tender offer to acquire Genelabs. At Dec. 29, there were 36.4 million shares tendered (see BioCentury, Nov. 3, 2008). ...